ArticleJapanese journal of clinical oncology2019

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study.

Kazuhiro Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.